Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025

by Seini Moimoi | May 3, 2025 | Portfolio News

Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

by Seini Moimoi | Apr 28, 2025 | Portfolio News

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

by Seini Moimoi | Apr 26, 2025 | Portfolio News

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

by Seini Moimoi | Apr 24, 2025 | Portfolio News

Endeavor BioMedicines Appoints Internationally Renowned ILD Expert Lisa Lancaster, M.D., as Chief Medical Officer

by Seini Moimoi | Apr 2, 2025 | Portfolio News

Cohere Health Launches Cohere Align to Move Beyond Gold Carding with Smarter Prior Authorization for Health Plans

by Seini Moimoi | Mar 25, 2025 | Portfolio News

MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery

by Seini Moimoi | Mar 12, 2025 | Portfolio News

Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights

by Seini Moimoi | Mar 10, 2025 | Portfolio News

Cohere Health and American Academy of Orthopaedic Surgeons Expand Collaboration to Drive Quality Musculoskeletal Care

by Seini Moimoi | Mar 10, 2025 | Portfolio News

Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering

by Seini Moimoi | Mar 5, 2025 | Portfolio News

« Older Entries
Next Entries »

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2025 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer